Recently, activating MPL mutations, MPLW515L/K, were described in myeloproliferative disorders (MPD) patients. MPLW515L leads to activation of downstream signaling pathways and cytokine-independent proliferation in hematopoietic 
Introduction
Myeloproliferative disorders (MPDs) are a group of diseases characterized by increased numbers of one or several of the myeloid lineages. The activating JAK2 mutation, JAK2V617F, associated with these disorders, leads to constitutive activation of JAK2 without the need of ligand binding to hematopoietic receptors (1, 2) . Recently, gain-of-function mutations in the MPL receptor (Tpo receptor), MPLW515L/K, were described in a subset of MPD patients (3, 4) , suggesting that proteins implicated in the MPL signaling axis could represent targets for therapeutic interventions in MPD. One such protein may be Lnk, an adaptor protein which is expressed predominantly in hematopoietic tissues and has critical roles in hematopoiesis (5) (6) (7) (8) (9) (10) . Animal model studies demonstrated that Lnk acts as a broad inhibitor of signaling pathways. Among pathways inhibited by Lnk are Thrombopoietin (Tpo)-induced proliferation and differentiation of megakaryocytes and Tpo-induced self-renewal in hematopoietic stem cells and myeloid progenitors (11, 12) . Lnk belongs to a family of proteins that share several structural motifs, including a Src homology 2 (SH2) domain which binds phosphotyrosines in various signal-transducing proteins (13) (14) (15) . The SH2 domain is essential for Lnk-mediated negative regulation of several cytokine receptors (i.e. MPL, EPOR and c-KIT) (8, 11, 16) . In the present study, we asked whether Lnk can attenuate the constitutive activity of MPLW515L.
Materials and Methods
Mice and cell culture. Lnk-deficient mice were generously provided by T.
Pawson (Samuel Lunenfeld Research Institute, Toronto, Canada). Bone marrow cells derived from 6-wk-old WT and Lnk-deficient 129/Sv mice were cultured in IMDM with 5% FBS, IL-3 (10 ng/mL) and GM-CSF (10 ng/mL) for 7 days. The cells were then washed and resuspended in IMDM with 5% FBS and Tpo (50 ng/ml) for 3 additional days to enrich the numbers of megakaryocytes. Lysates from 3 ×10 6 cells were used for reduced the growth rate of BaF/MPL515 and UT7/MPL515 cells ( Fig. 2A) , indicating that these signaling cascades are important for MPLW515L mediated cell proliferation.
To determine whether Lnk inhibition of cell proliferation is associated with JAK/STAT, MAPK and PI3K signaling, we assessed the phosphorylation levels of Jak2, Stat3, p42/44
Erk and Akt (downstream PI3K) in BaF/MPL515 cells. Overexpression of Lnk, but not Lnk R392E, inhibited the constitutive, as well as the Tpo-induced phosphorylation of these molecules (Fig. 2B) .
Lnk via its SH2 domain interacts with MPLWT and MPLW515L.
The molecular mechanisms by which Lnk inhibits Tpo signaling are largely (Fig. 3A) .
Lnk also bound to mutant MPLW515L in UT7 cells, and the interaction was stronger following Tpo stimulation (Fig. 3B) . Similarly, Lnk was found in MPLWT immunocomplexes in Tpo treated 293T cells overexpressing Lnk and MPLWT (Fig. 3C ).
In Confocal microscopy analysis demonstrated significant colocalization between V5-tagged-Lnk and both MPLWT and MPLW515L in BaF/3 cells (Fig. 4A, and supplementary Fig. 1 ). While Lnk was mostly found in the plasma membrane, in some cells it was present in the cytoplasm (data not shown). Moreover, membrane staining of Lnk was also noted in cells not expressing MPL, demonstrating that Lnk localizes to the membrane independent of its MPL association. To determine which domains of Lnk are required for its membrane expression, we transfected Lnk deletion mutants into 293T cells and analyzed their expression pattern. The point mutant, Lnk R392E, and a deletion mutant lacking the SH2 domain (ΔSH2) retained the capacity to localize to the plasma membrane, while further deletion of the PH domain (ΔPHSH2) abolished it (Fig. 4B) . In our system, WT Lnk localized mostly to the membrane. Previously, Lnk-GFP expressed in COS-7 cells, was found mostly in the juxtanuclear region with some membrane localization (15) . The discrepancy could arise from different experimental conditions and vectors used.
Discussion
In the present study we show that Lnk is a negative regulator of MPLW515L. Lnk 
